Product image of Norlevo (Levonorgestrel) supplied by GNH India

Norlevo

Active Ingredient:
Levonorgestrel
Origin:
EU

Norlevo (Levonorgestrel)

Levonorgestrel, the active ingredient in Norlevo, is a progestin presented as a 1.5 mg tablet for oral use. It is used as an emergency contraceptive to prevent pregnancy after unprotected intercourse and works by delaying ovulation, potentially inhibiting fertilization and altering endometrial receptivity. It is available over‑the‑counter in many EU countries and is indicated for use within 72 hours of intercourse.

GNH India supplies Norlevo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for cross‑border distribution.

Manufacturer / TM Owner

Laboratoire Hra Pharma

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Levonorgestrel in Norlevo is used as an emergency contraceptive acting on the reproductive hormonal pathway.

  • Unprotected sexual intercourse: reduces the risk of pregnancy when administered within 72 hours after exposure.
  • Contraceptive failure (e.g., missed oral contraceptive pill): offers a backup method to prevent unintended pregnancy.
  • Post‑coital emergency use: provides a non‑prescription option for immediate pregnancy prevention.

How It Works

  • Levonorgestrel binds to progesterone receptors in the hypothalamic‑pituitary‑ovarian axis, suppressing the luteinizing hormone surge and thereby delaying or inhibiting ovulation. It may also impair tubal transport of sperm or ova and modify endometrial receptivity, reducing the likelihood of fertilization and implantation when taken after coitus.

Side Effects

Levonorgestrel is generally well tolerated, but several adverse reactions have been reported.

Common Side Effects

  • Nausea: mild to moderate upset stomach occurring shortly after ingestion.
  • Headache: transient tension‑type headache.
  • Abdominal pain or cramps: discomfort in the lower abdomen.
  • Menstrual changes: spotting, earlier or later onset of the next period.
  • Fatigue or dizziness: temporary feeling of tiredness.

Serious or Rare Side Effects

  • Allergic reaction: rash, itching, swelling, or anaphylaxis.
  • Severe abdominal pain: may indicate ectopic pregnancy.
  • Chest pain or shortness of breath: possible cardiovascular involvement.
  • Persistent vomiting: could lead to dehydration.
  • Liver dysfunction: jaundice or abnormal liver enzymes.

Precautions & Warnings

Before using Norlevo, consider the following safety measures.

  • Timing of intake: take as soon as possible after unprotected intercourse, ideally within 72 hours.
  • Pregnancy status: not indicated for use during an established pregnancy.
  • Breastfeeding: consult a healthcare professional before use.
  • Drug interactions: avoid concomitant use with enzyme‑inducing medicines that may lower effectiveness.
  • Medical conditions: use with caution in women with known hormonal disorders or liver disease.
  • Store at ambient temperature: keep below 25°C in the original packaging, protected from moisture and direct sunlight.

Avoid Interactions

Levonorgestrel may interact with other medicines, altering its efficacy.

Major Interactions (Avoid)

  • Rifampicin, carbamazepine, phenytoin, St. John’s wort: strong enzyme inducers that can markedly reduce contraceptive effectiveness.
  • Antiepileptic drugs: may lower plasma levels of levonorgestrel.

Moderate Interactions (Monitor Closely)

  • Antifungal azoles (e.g., ketoconazole): may increase levonorgestrel concentrations.
  • HIV protease inhibitors: can affect hormone metabolism.
  • Hormonal contraceptives: concurrent use may require additional counseling to ensure adequate protection.

Frequently Asked Questions

Norlevo is an oral emergency contraceptive containing levonorgestrel. It is intended to reduce the risk of pregnancy after unprotected sexual intercourse, contraceptive failure, or any situation where additional birth control is needed within a short time frame.

Levonorgestrel acts by binding to progesterone receptors, suppressing the luteinizing hormone surge and thereby delaying or preventing ovulation. It may also affect sperm or egg transport and alter the endometrial lining, reducing the chance of fertilization and implantation.

The prescribed dose of Norlevo is determined by a qualified healthcare professional. Typically, the product contains a single 1.5 mg tablet that is taken orally as directed by the prescriber or pharmacist.

Norlevo is not intended for use during an established pregnancy. If pregnancy is confirmed after taking the tablet, medical advice should be sought. Limited data exist for breastfeeding; women should discuss potential risks with their healthcare provider before use.

To order Norlevo, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Norlevo contains levonorgestrel, a progestin‑only emergency pill, which is effective up to 72 hours after intercourse. Alternative options include ulipristal acetate, a selective progesterone receptor modulator with a slightly longer efficacy window, and copper IUD insertion, which provides the most effective post‑coital contraception.

Store Norlevo tablets at ambient temperature, below 25 °C, in the original blister pack. Keep the medication away from moisture, direct sunlight and out of reach of children. Do not use if the packaging is damaged or the tablets appear discolored.

Norlevo is taken orally as a single tablet. The tablet should be swallowed whole with water, preferably as soon as possible after unprotected intercourse and no later than 72 hours after the event.

Serious but rare risks include severe allergic reactions such as anaphylaxis, ectopic pregnancy, and significant abdominal pain that may indicate complications. Any signs of severe reaction or persistent pain should prompt immediate medical attention.

Norlevo should be avoided by individuals with a known hypersensitivity to levonorgestrel or any tablet excipients, women who are already pregnant, and those with certain hormonal disorders or severe liver disease unless advised otherwise by a healthcare professional.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Levonorgestrel

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT